Axiom Real-Time Metrics Receives Investment from Great Point Partners
TORONTO, May 08, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, today announces significant strategic growth funding. The investment has been led by Great Point Partners (“GPP”), a leading health care investment firm with approximately $1.6 billion of equity capital currently under management.
This event marks a significant milestone for Axiom, which was founded in 2001. Axiom, an established player in the eClinical market, is unique in its position in this space, as its significant growth has been accomplished through reinvestment of revenue, rather than through external investment. A strategic and pivotal decision for the organization, the collaboration with GPP represents the first investment of outside capital that Axiom has taken on.
The investment by GPP will position Axiom to accelerate the development and addition of leading-edge elements to its Fusion eClinical platform. Additionally, funds will be utilized to significantly expand professional services and business development initiatives.
“Our decision to work with Great Point Partners is based on our synergies, their hyper-focused area of life sciences, and the deep understanding of the space that they bring to the table. We are thrilled to be bringing onboard our first investment into Axiom with a group of their caliber”, shared Andrew Schachter, Founder and CEO.
Axiom is currently the leading provider of eClinical software and associated services to small to medium sized life sciences companies. It’s eClinical suite, Fusion, is enterprise level in its depth and scope, with all of its technology developed in-house. A key message of Axiom “We think differently”, is delivered upon through powerful, flexible and tailored solutions , priced to suit the needs of this small to medium-sized market, and providing service and a level of dedication in its client partnerships that is unmatched.
Andrew Schachter, Founder and CEO, continued, “I am very excited about GPP’s investment into Axiom that we are announcing today. Axiom has experienced tremendous continued growth over the past several years. My team and I have grown the company for over 18 years without taking external capital to date. We have built the Fusion eClinical Suite into the world class leading enterprise platform for EDC, IWRS, ePRO and CTMS operations focused on small to medium life sciences. As we continue to expand, this investment will augment innovation and resources for the breadth and depth of the Fusion platform, its modules and the accompanying services we wrap around them. We have a lot of exciting technologies and features to be released over the next few quarters to share with our clients.”
About Axiom Real-Time Metrics
Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: Data Management, Data Analytics, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with approximately $1.5 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP II, which closed on $215 million. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has over $280 million in committed capital) and public (BioMedical Value Fund, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at 203-971-3300 or www.gppfunds.com.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
BOURBON: Press release - Update on the search operations of the Bourbon Rhode crew12.10.2019 09:00:00 CEST | Press release
Marseilles, October 12, 2019 Update on the search operations of the Bourbon Rhode crew Following the report of a possible distress flare on the night of Sunday 6 to Monday October 7, the CROSS French West Indies-Guyana (Regional Operational Centre for Surveillance and Rescue) dispatched 4 ships to search the area, with the support of an overflight by the US Coast Guards aircraft. Over the past week, search has been intense and extensive to try to detect a sign after on the one hand, the report of this potential distress flare and on the other hand, the satellite photo obtained from the European Maritime Safety Agency (EMSA). These new searches have unfortunately been unsuccessful. As a whole, search operations have not found any trace of life or life rafts for more than 10 days now despite measures of exceptional magnitude. As a reminder, search and rescue operations have been going on for 16 days, with the sinking of the ship taking place on September 26 as it faced hurricane Lorenzo.
Agfa-Gevaert: Publication of a transparency notification (AOC) – Regulated information11.10.2019 17:40:00 CEST | Press release
(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium – October 11, 2019 – 5.40 p.m. CET According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%. In conformity with the Law of May 2, 2007 regarding the disclosure of significant shareholdings in listed companies, Agfa-Gevaert (Euronext: AGFB) discloses the following declaration: Active Ownership Capital S.à.r.l. has announced on April 18, 2019, that it managed a stake in Agfa-Gevaert as per April 12, 2019 of 23,069,853 voting rights or 13.42% (denominator is 171,851,042). On this date, AOC Value S.A.S. individually held 13,402,784 voting rights or 7.80%. On April 12, 2019, Active Ownership Fund SICAV-FIS SCS contributed 4,535,000 shares already held by it in Agfa-Gevaert NV to AOC Technology S.A.S., as a result of which AOC Technology S.A.S. directly holds 9,667,069 voting rights or 5.63% of Agfa-
DNO ASA: Mandatory Notification of Trade11.10.2019 16:56:00 CEST | Press release
Oslo, 11 October 2019 - DNO ASA, the Norwegian oil and gas operator, has today purchased 1,900,000 own shares at an average price of NOK 13.0887 per share. Following this transaction, DNO holds 73,200,000 own shares. -- For further information, please contact: Media: email@example.com Investors: firstname.lastname@example.org -- DNO ASA is a Norwegian oil and gas operator focused on the Middle East and the North Sea. Founded in 1971 and listed on the Oslo Stock Exchange, the Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in the Kurdistan region of Iraq, Norway, the United Kingdom, Netherlands, Ireland and Yemen. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
PRF: Unaudited preliminary consolidated turnover of AS PRFoods in the 3rd quarter of 201911.10.2019 16:28:00 CEST | Press release
PRFoods’ unaudited preliminary consolidated turnover in 3Q 2019 (i.e. 1Q of the fiscal year 2019/2020) amounted to EUR 19.32 million euros (19.40 million euros in 3Q 2018). The third quarter of 2019 was characterized by a general decline of raw material prices for fish products, resulting in lower prices for both fish and fish fillets, and smoked products. Despite the ca 5% decrease in the price of the Group’s main products, we managed to increase the share of other fish products and keep the total turnover largely at the level of last year. The turnover of other fish products increased by 1.01 million euros, whereas turnover from smoked fish product group and raw fish and fillets’ product group decreased by 0.54 million euros and 0.48 million euros, respectively. The Group’s revenue structure has changed both in regard to product groups as well as client groups compared to the same period a year ago. The share of other fish products increased by 5.30 percentage points. The share of ra
Conditions for Inflation-linked auctions11.10.2019 16:20:00 CEST | Press release
Sveriges Riksbank Bid procedure details Inflation-linked Government Bonds, 2019-10-18 Maturity date Loan ISIN code Coupon Volume, SEK million 2026-06-01 3112 SE0008014062 0.125 % 250 +/- 250 2028-12-01 3104 SE0000556599 3.50 % 250 +/- 250 Settlement date 2019-10-22 Bids have to be entered by 10.00 on OCT 18, 2019 Highest permitted bid volume: 250 SEK million Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.10 (CEST) ON OCT 18, 2019. For more information, please contact: Trading desk at the Riksbank + 46 8 696 6970 General and special terms and conditions can be retrieved at http://www.riksbank.se
Conditions for Riksbank Bid Procedures Sek Bonds11.10.2019 16:20:00 CEST | Press release
Sveriges Riksbank Bid procedure details Government Bonds, 2019-10-17 Maturity date Loan ISIN code Coupon Volume, SEK million 2023-11-13 1057 SE0004869071 1.50 % 500 +/- 250 2029-11-12 1061 SE0011281922 0.75 % 500 +/- 250 Settlement date 2019-10-21 Bids have to be entered by 10.00 on OCT 17, 2019 Highest permitted bid volume: 500 SEK million in issue SGB 1057 and 500 SEK million in issue SGB 1061 Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.10 (CEST) ON OCT 17, 2019. For more information, please contact: Trading desk at the Riksbank + 46 8 696 6970 General and special terms and conditions can be retrieved at http://www.riksbank.se